Struggling Sensyne Health replaces founder with new CEO
The founder and CEO of Sensyne Health plc is to leave the Oxford company. Labour peer Lord Drayson, who founded the company in 2018 to accelerate the role of artificial...
Category: Competitor News
Exscientia Presents Three Posters Demonstrating Potential of Precision Medicine Platform in Drug Discovery at the American Association of Cancer Research Annual Meeting 2022
April 08, 2022 04:01 PM Eastern Daylight Time OXFORD, England & VIENNA, Austria–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) today shared details of its participation at the upcoming American Association for Cancer...
IQVIA doesn’t yet have the golden egg of AI, but it’s in ‘incubation’
Gary Shorter, head of AI and data science at healthcare data goliath IQVIA, is not in a rush as he incorporates machine learning into the company’s suite of services. But...
Novartis breast cancer drug approved for ultra-rare condition
Dive Brief: The Food and Drug Administration has approved the first drug to treat an ultra-rare cluster of conditions caused by mutations in a specific gene, granting an accelerated clearance to...
Clarify Health Closes $150M Series D Funding to Unlock the Promise of Value-Based Care with End-to-End Intelligence on Every Patient Journey
April 05, 2022 09:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Clarify Health, a leading cloud analytics and value-based payments platform company, announced today that it secured $150 million in Series...
Real-world Data Show Benefits of Increased Lung Cancer Screening but Persistent Disparities
New research published in The BMJ indicates the introduction of low dose CT (LDCT) screening in 2013 coincided with improved survival and a shift toward diagnoses of stage I non–small cell lung...
Cytel appoints first CMO to accelerate the expansion of analytics and innovation
Cytel has appointed Albert Kim, MD, PhD, as its first Chief Medical Officer (CMO), driving expansion of the advanced analytics capabilities available to clinicians looking to streamline therapeutic development. Dr...
Emmaus Life Sciences Presented Positive Real-World Data on the Efficacy of Endari® in Preventing Acute Complications from Sickle Cell Disease at the 62nd Annual Scientific Meeting of the British Society for Haematology
Sickle Cell Patients Treated With Endari® had Statistically Significantly Fewer Vaso-Occlusive Events and Hospitalizations Through 72 Weeks Follow-up, Versus Baseline Adverse Events Among These Patients from French Guiana and Qatar were Few and Mild TORRANCE,...
Savana gets $25 million booster to make clinical research more powerful with big data
The Madrid-based company plans to enter the drugs research space while also consolidating its footprint in America and Western Europe Megha Paul 05 April 2022 Real World Data, or the...
Foundation Medicine and Collaborators to Share Scientific Advances at AACR22 Reinforcing the Power of Genomic Testing in Precision Cancer Care
New studies demonstrate the ability of Foundation Medicine’s portfolio of tests to improve treatment options for patients, and reinforce the company’s role as an essential partner to researchers April 05,...